Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.

Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Sept 2017

Jiang Ni, Qiao Guoliang, Wang Xiaoli, Morse Michael A, Gwin William R, Zhou Lei, Song Yuguang, Zhao Yanjie, Chen Feng, Zhou Xinna, Huang Lefu, Hobeika Amy, Yi Xin, Xia Xuefeng, Guan Yanfang, Song Jin, Ren Jun, Lyerly H Kim

Abstract excerpt

Purpose: Advanced pancreatic cancer has remained challenging to treat effectively. This study aimed to investigate the clinical effects and safety of immunotherapy with dendritic cells and cytokine-induced killer cells (DC-CIK) administered with the chemotherapy (CT) S-1 in this malignancy.Experimental Design: Consecutive patients (n = 47) with advanced pancreatic cancer were treated with either DC-CIK + S-1,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circulating Tumor DNA
Share to Combined Modality Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Dendritic Cells

Share to Disease-Free Survival

Share to Drug Combinations

Share to Immunotherapy, Adoptive

Share to Pyridines

Share to T-Lymphocyte Subsets

Source

Identifiers

PMID: 28611200
DOI: 10.1158/1078-0432.CCR-17-0492

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dendritic Cell/Cytokine-Induced Killer Cell Immunotherapy Combined with S-1 in Patients with Advanced Pancreatic Cancer: A Prospective Study.PMID 28611200Read ↗

Advancing Immunotherapy in Pancreatic Cancer: A Brief Review of Emerging Adoptive Cell TherapiesSemantic proximity Read ↗

Immunotherapy Combined with Chemotherapy versus Chemotherapy Alone in Advanced Pancreatic Ductal Adenocarcinoma: a Real-world Retrospective Cohort StudySemantic proximity Read ↗

Current and future therapies for advanced pancreatic cancer.Semantic proximity Read ↗

Clinical Applications of Combined İmmunotherapy Approaches in Gastrointestinal Cancer: A Case-Based ReviewSemantic proximity Read ↗

A Double-blind Randomized Comparative Clinical Trial to Evaluate the Safety and Efficacy of Dendritic Cell Vaccine Loaded with WT1 Peptides (TLP0-001) in Combination with S-1 in Patients with Advanced Pancreatic Cancer Refractory to Standard ChemotherapySemantic proximity Read ↗

Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activitySemantic proximity Read ↗

A phase I pilot trial of MUC1-peptide-pulsed dendritic cells in the treatment of advanced pancreatic cancer.Semantic proximity Read ↗

A Peptide-Based Neoantigen Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard TreatmentSemantic proximity Read ↗

Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors.Semantic proximity Read ↗

Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined TherapiesSemantic proximity Read ↗

Exploring prognostic survival factors in patients with advanced pancreatic cancer receiving PD-1 inhibitorsSemantic proximity Read ↗

Strength in Unity: a Dual Strategy to Restore NK Cell Cytotoxicity against Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.